Author

Tuğba Kaya

h-index 3 View on Semantic Scholar

We have 2 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Clinicopathologic and Treatment-Related Determinants of Pathologic Complete Response and Survival Outcomes in Triple-Negative Breast Cancer: A Real-World Cohort Study

Background: Pathological complete response (pCR) following neoadjuvant systemic therapy is an important prognostic indicator in triple-negative breast cancer (TNBC). Nevertheless, identifying clinicopathological characteristics associated with treatment response remains essential. This study aimed to evaluate factors a...

Tuğba Kaya, Sedat Yıldırım, Nisanur Sarıyar Busery et al. · Biomedicines · 0 citations

Open access Sep 2026

Treatment Outcomes and Toxicity of Cisplatin–Etoposide-Based Regimens and Carboplatin–Paclitaxel as Adjuvant Chemotherapy for Ovarian Adult Granulosa Cell Tumors: A Multicenter Retrospective Cohort Study

Simple Summary Adult granulosa cell tumors of the ovary are rare malignancies, and the role of adjuvant chemotherapy after surgery remains uncertain. Bleomycin–etoposide–cisplatin has traditionally been used, while carboplatin–paclitaxel has increasingly been adopted as an alternative regimen. This multicenter retrospe...

A. Geçgel, Mehmet Uzun, Mehmet Burak Kaya et al. · Cancers · 0 citations